Jun 23
|
The Zacks Analyst Blog Highlights Meta, Palantir, Abbott Laboratories, SandRidge and CompX
|
Jun 20
|
New Research on Abbott's Healthy Food Rx Program Shows 'Food is Medicine' Approach Helps People Living With Diabetes Eat Better and Feel Healthier
|
Jun 20
|
Top Research Reports for Meta Platforms, Palantir & Abbott
|
Jun 20
|
Abbott Laboratories (NYSE:ABT) Enhances Diabetes Care And Partners With Abu Dhabi For Pharma Expansion
|
Jun 20
|
DXCM's Access Gains and Operational Strength Offset Margin Pressures
|
Jun 20
|
Tandem Diabetes Care Announces t:slim X2™ Insulin Pump Compatibility with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States
|
Jun 20
|
5 things to watch at the ADA’s Scientific Sessions
|
Jun 19
|
ABT's i-STAT TBI Test Receives Approval in Canada: Stock to Rise?
|
Jun 19
|
Abbott Laboratories (NYSE:ABT) is a favorite amongst institutional investors who own 81%
|
Jun 19
|
Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor
|
Jun 18
|
Esker Expands European Field Presence with New Office in Ghent, Belgium
|
Jun 18
|
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
|
Jun 18
|
Leerink Partners Begins Coverage on ABT
|
Jun 17
|
3 Dividend Growth Stocks To Buy and Hold Forever
|
Jun 17
|
Abbott, Tandem Diabetes Care Partner For Glucose-Ketone Sensor for Diabetes Management
|
Jun 17
|
Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q1 Earnings?
|
Jun 16
|
Leerink starts coverage on Boston Scientific and Medtronic with bullish ratings
|
Jun 16
|
Abbott Receives Health Canada Authorization for Whole Blood Rapid Test to Help Assess Suspected Concussions
|
Jun 16
|
1 Unpopular Stock that Should Get More Attention and 2 to Avoid
|
Jun 12
|
Abbott Laboratories Stock Sees RS Rating Rise To 82
|